Format

Send to

Choose Destination
See comment in PubMed Commons below
Med J Aust. 2014 Mar 17;200(5):267-70.

Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update.

Author information

1
Barwon Health, Geelong, VIC, Australia. danielo@barwonhealth.org.au.
2
Southern Health, Melbourne, VIC, Australia.
3
Cornell Specialist Centre, Melbourne, VIC, Australia.
4
Cairns Base Hospital, Cairns, QLD, Australia.
5
Barwon Health, Geelong, VIC, Australia.
6
Point Lonsdale Medical Group, Point Lonsdale, VIC, Australia.
7
St John of God Hospital, Geelong, VIC, Australia.
8
Austin Health, Melbourne, VIC, Australia.

Abstract

• Guidelines reflecting contemporary clinical practice in the management of Buruli ulcer (Mycobacterium ulcerans infection) in Australia were published in 2007. • Management has continued to evolve, as new evidence has become available from randomised trials, case series and increasing clinical experience with oral antibiotic therapy. • Therefore, guidelines on the diagnosis, treatment and prevention of Buruli ulcer in Australia have been updated. They include guidance on the new role of antibiotics as first-line therapy; the shortened duration of antibiotic treatment and the use of all-oral antibiotic regimens; the continued importance, timing and role of surgery; the recognition and management of paradoxical reactions during antibiotic treatment; and updates on the prevention of disease.

PMID:
24641151
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Australasian Medical Publishing Company
    Loading ...
    Support Center